Advances in Immunology
- 1st Edition, Volume 153 - April 23, 2022
- Editors: Frederick W. Alt, Kenneth Murphy
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 8 9 4 1 - 1
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 8 9 4 2 - 8
Advances in Immunology, Volume 153, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immuno… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteAdvances in Immunology, Volume 153, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology, with this volume covering Regulatory T Cells in Infection and Factor H and Properdin and their regulation.
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the advancing area of the mechanisms involved in the evolution of regulatory T-cells in infection and Factor H and Properdin and their regulation
- Cover image
- Title Page
- Table of Contents
- Copyright
- Contributors
- Chapter One: The role of properdin and Factor H in disease
- Abstract
- 1: Introduction
- 2: Complement system overview
- 3: Overview of complement regulation
- 4: Negative regulation of the AP by FH
- 5: Positive regulation of the AP by properdin
- 6: Conclusion
- Acknowledgment
- References
- Chapter Two: Becoming aware of γδ T cells
- Abstract
- 1: Introduction
- 2: A TCR-like gene without a known function
- 3: Activation of γ genes in the thymus
- 4: Lymphocytes expressing the γ protein on their surface
- 5: The nature of the δ protein
- 6: γδ T cells everywhere
- 7: After the discovery
- Acknowledgment
- References
- No. of pages: 126
- Language: English
- Edition: 1
- Volume: 153
- Published: April 23, 2022
- Imprint: Academic Press
- Hardback ISBN: 9780323989411
- eBook ISBN: 9780323989428
FA
Frederick W. Alt
Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Affiliations and expertise
Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USAKM
Kenneth Murphy
Kenneth M. Murphy works in Washington University School of Medecine, USA.
Affiliations and expertise
Washington University School of Medecine, USARead Advances in Immunology on ScienceDirect